TG Therapeutics, Inc. SEC filings TGTX

TG Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 28, 2003. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Feb 27, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 3, 2025 Dec 31, 2024
10-K/A Amended annual report Aug 9, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Feb 29, 2024 Dec 31, 2023
10-K Annual report Mar 1, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
10-K Annual report Mar 2, 2020 Dec 31, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
10-K Annual report Mar 15, 2018 Dec 31, 2017
10-K/A Amended annual report Mar 21, 2017 Dec 31, 2016
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K Annual report Mar 15, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2015 Dec 31, 2014
10-K Annual report Mar 7, 2014 Dec 31, 2013
10-K/A Amended annual report Jun 10, 2013 Dec 31, 2012
10-K Annual report Mar 21, 2013 Dec 31, 2012
10-K Annual report Mar 14, 2012 Dec 31, 2011
10-K Annual report Mar 31, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2009 Dec 31, 2008
10-K/A Amended annual report Apr 29, 2008 Dec 31, 2007
10-K Annual report Mar 31, 2008 Dec 31, 2007

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TGTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1001316
Former names
MANHATTAN PHARMACEUTICALS INC (until Apr 27, 2012); ATLANTIC TECHNOLOGY VENTURES INC (until Mar 10, 2003); ATLANTIC PHARMACEUTICALS INC (until Feb 4, 2000)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.